Dana-Farber Cancer Institute: Patients with multiple myeloma and CHIP often have worse outcomes following autologous stem cell transplant, study finds

  • Tarek Mouhieddine

Press/Media

Period12 Jun 2020 → 13 Jun 2020

Media coverage

2

Media coverage

  • TitlePatients With Multiple Myeloma and CHIP Often Have Worse Outcomes Following Autologous Stem Cell Transplant, Study Finds
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date13/06/20
    PersonsTarek Mouhieddine
  • TitleDana-Farber Cancer Institute: Patients with multiple myeloma and CHIP often have worse outcomes following autologous stem cell transplant, study finds
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date12/06/20
    PersonsTarek Mouhieddine